References
- Conceptus(R) Receives FDA Approval On Essure’s Bilateral Placement Rate To 96.9% [press release]. May 19, 2010. [cited December 4, 2011]. Available from: http://www.reuters.com/article/2010/05/18/idUS226590+18- May-2010+BW20100518. Accessed December 4, 2011.
- Conceptus Essure 305 Instructions for Use [homepage on the Internet]. Mountain View: Conceptus Incorporated [updated 2007; cited December 4, 2011]. Available from: http://www.Essure.com. Accessed December 4, 2011.
- Panel P, Grosdemouge I. Predictive factors of Essure implant placement failure: prospective, multicenter study of 495 patients. Fertil Steril. 2010;93(1):29–34.
- Cooper JM, Carignan CS, Cher D, Kerin JF. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol. 2003;102(1):59–67.
- Kerin JF, Munday DN, Ritossa MG, Pesce A, Rosen D. Essure hystero- scopic sterilization: results based on utilizing a new coil catheter delivery system. J Am Assoc Gynecol Laparosc. 2004;11(3):388–393.
- Shavell V Abdallah ME, Shade GH Jr, Diamomd MP, Berman JM. Trends in sterilization since introduction of Essure hysterocopic sterilization. J Minim Invasive Gynecol. 2009;16(1):22–27.
- Miño M, Arjona JE, Cordón J, Pelegrin B, Povedano B, Chacon E. Success rate and patient satisfaction with the Essure sterilisation in an outpatient setting: a prospective study of 857 women. BJOG. 2007;114(6):763–766.
- Rosen DM. Learning curve for hysteroscopic sterilisation: lessons from the first 80 cases. Aust N Z J Obstet Gynaecol. 2004;44(1):62–64.
- Nichols M, Carter JF, Fylstra DL, Childers M. A comparative study of hysteroscopic sterilization performed in-office versus a hospital operating room. J Minim Invasive Gynecol 2006;13(5):447–450.
- RxList the internet drug index [homepage on the Internet]. New York: WebMD [cited December 05, 2011]. Available from: http://www.rxlist. com/levsin-drug.htm. Accessed December 5, 2011.
- Fuller J, Scott W, Ashar B, Corrado J. Laparoscopic Trocar Injuries: A report from a US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) Systematic Technology Assessment of Medical Products (STAMP) Committee. Silver Spring, MD: US Food and Drug Administration; 2003. Available from: http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm197339.htm. Accessed January 3, 2011.